Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 488

    1.

    Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

    Schuman P, Capps L, Peng G, Vazquez J, el-Sadr W, Goldman AI, Alston B, Besch CL, Vaughn A, Thompson MA, Cobb MN, Kerkering T, Sobel JD.

    Ann Intern Med. 1997 May 1;126(9):689-96.PMID: 9139554 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

    Pienaar ED, Young T, Holmes H.

    Cochrane Database Syst Rev. 2006 Jul 19;3:CD003940. Review.PMID: 16856025 [PubMed - indexed for MEDLINE]Related articles

    5.

    Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.

    Barbaro G, Barbarini G, Di Lorenzo G.

    Endoscopy. 1995 Jun;27(5):377-83.PMID: 7588352 [PubMed - indexed for MEDLINE]Related articles

    7.

    Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.

    Vazquez JA, Peng G, Sobel JD, Steele-Moore L, Schuman P, Holloway W, Neaton JD.

    Clin Infect Dis. 2001 Oct 1;33(7):1069-75. Epub 2001 Sep 5.PMID: 11528582 [PubMed - indexed for MEDLINE]Related articles

    8.

    Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.

    Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.

    Clin Infect Dis. 2008 Nov 15;47(10):1270-6.PMID: 18840077 [PubMed - indexed for MEDLINE]Related articles

    9.

    A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.

    Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG; AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40.

    Clin Infect Dis. 2005 Nov 15;41(10):1473-80. Epub 2005 Oct 12.PMID: 16231260 [PubMed - indexed for MEDLINE]Related articles

    10.

    Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

    Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C 3rd, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC.

    N Engl J Med. 2004 Aug 26;351(9):876-83.PMID: 15329425 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

    Pelletier R, Peter J, Antin C, Gonzalez C, Wood L, Walsh TJ.

    J Clin Microbiol. 2000 Apr;38(4):1563-8.PMID: 10747144 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.

    Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A; HIV Epidemiology Research Study (HERS) Group.

    J Infect Dis. 2001 Jan 15;183(2):286-93.PMID: 11204125 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study.

    Marriott DJ, Jones PD, Hoy JF, Speed BR, Harkness JL.

    Med J Aust. 1993 Mar 1;158(5):312-6.PMID: 8097273 [PubMed - indexed for MEDLINE]Related articles

    14.

    A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.

    Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R.

    Clin Infect Dis. 2006 Apr 15;42(8):1179-86. Epub 2006 Mar 14.PMID: 16575739 [PubMed - indexed for MEDLINE]Related articles

    15.

    A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

    Revankar SG, Kirkpatrick WR, McAtee RK, Dib OP, Fothergill AW, Redding SW, Rinaldi MG, Hilsenbeck SG, Patterson TF.

    Am J Med. 1998 Jul;105(1):7-11.PMID: 9688014 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.

    Manfredi R, Mastroianni A, Coronado OV, Chiodo F.

    Arch Intern Med. 1997 Jan 13;157(1):64-9.PMID: 8996042 [PubMed - indexed for MEDLINE]Related articles

    17.

    Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

    Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T.

    Crit Care Med. 1999 Jun;27(6):1066-72.PMID: 10397206 [PubMed - indexed for MEDLINE]Related articles

    18.

    Weekly fluconazole to prevent candida.

    Gilden D.

    GMHC Treat Issues. 1996 Jun-Jul;10(6/7):16.PMID: 11363636 [PubMed - indexed for MEDLINE]Related articles

    19.

    Discontinuation of prophylaxis for Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

    El-Sadr WM, Burman WJ, Grant LB, Matts JP, Hafner R, Crane L, Zeh D, Gallagher B, Mannheimer SB, Martinez A, Gordin F.

    N Engl J Med. 2000 Apr 13;342(15):1085-92.PMID: 10766581 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.

    Goldman M, Cloud GA, Smedema M, LeMonte A, Connolly P, McKinsey DS, Kauffman CA, Moskovitz B, Wheat LJ.

    Antimicrob Agents Chemother. 2000 Jun;44(6):1585-7.PMID: 10817713 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data